C
DexCom, Inc. DXCM
$84.67 -$0.67-0.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -28.01% -40.81% 11.52% 23.81% 201.23%
Total Depreciation and Amortization 14.29% 7.97% 14.73% 19.22% 26.20%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 306.90% 3.61% 90.11% 200.62% -163.50%
Change in Net Operating Assets -97.89% 102.48% -90.31% 44.44% -63.11%
Cash from Operations -12.14% 125.60% -25.89% 46.82% 34.62%
Capital Expenditure -52.90% -137.33% -120.63% -12.03% 23.83%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 42.14% -138.32% 349.03% 75.29% 217.59%
Cash from Investing 33.96% -173.20% 217.16% 66.02% 140.06%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 5.97% -- 3.50% -- 8.94%
Repurchase of Common Stock -- 100.00% -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 80.46% -132.65% -8.33% 98.63% -690.91%
Cash from Financing 165.96% 99.75% -15.55% -100.15% -58.04%
Foreign Exchange rate Adjustments 160.53% -283.61% 345.71% 54.55% -445.45%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 4.88% 80.47% 42.29% -84.59% 1,599.47%